The presence of CD163 among these five genes correlated with adverse outcomes, supports the association between CD163+ M2-type MΦ infiltration and higher risk of adverse PCa outcomes observed within the immunohistochemistry cohort. The gene discussed is CD163; the disease is posterior cortical atrophy.